Philippe Talaga

Company: Sanofi

Job title: Global Head of Research Platforms, CMC Leaders & Experts

Seminars:

Unlocking the Importance for Adaptability for Release Assays & Navigating the Regulatory Seas For The Development of Effective mRNA Vaccine 11:30 am

Could we consider the current mRNA vaccine regulatory landscape as foggy? Emphasize the importance of adaptability in the context of fast changing environment How can we differentiate the release and characterisation assays for mRNA vaccines? Using Analytical Platform Technologies and life cycle management to support accelerated mRNA vaccines developmentRead more

day: Conference Day One

Navigating Existing Standards & Regulatory Requirements for Analytical Development of mRNA Vaccines to Ensure a Streamlined Approval 9:31 am

Reviewing standards and regulatory requirements is critical for mRNA vaccines. In order to do so, we can look at the entire process from research and development to clinical trials and postmarket surveillance. This includes evaluating the manufacturing process, assessing the safety and efficacy of the vaccine, and monitoring for any adverse events. Additionally, it’s important…Read more

day: Pre-Conference Workshop Day